Іздеу

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Том 30, № 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Том 30, № 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

№ 20 (2014)

Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta

Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.

(Rus)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

№ 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

News of medicine

Kudinova S.

(Rus)

№ 16 (2012)

Monogennye formy sakharnogo diabeta

Zubkova N., Tikhonovich Y., Tyul'pakov A.

(Rus)

Том 28, № 12 (2021)

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

Том 27, № 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

№ 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

№ 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

№ 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

№ 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

№ 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

№ 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

Combination of two hypoglycemic drugs for type 2 diabetes mellitus

Morgunova T., Fadeyev V.

(Rus)

Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus

Izhbuldina G., Novikova L.

(Rus)

№ 11 (2018)

Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)

Demidov N., Mishra O., Antsiferov M.

(Rus)

№ 4 (2018)

POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME

Biryukova E., Solovyeva I., Platonova N.

(Rus)

№ 16 (2017)

Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy

Elsukova O., Sobolev A.

(Rus)

№ 6 (2017)

POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY

Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.

(Rus)

№ 5 (2017)

SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS

Girsh Y., Veliyeva O.

(Rus)

№ 16 (2016)

Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety

Antsiferov M., Schernthaner G.

(Rus)

№ 17 (2015)

10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -

Rybkina I., Petryaykina E., Koltunov I.

(Rus)

№ 5 (2015)

Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem

Antsiferov M., Koteshkova O.

(Rus)

№ 16 (2013)

Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa

Ametov A.

(Rus)

№ 16 (2013)

Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa

Biryukova E., Danilova T.

(Rus)

№ 5 (2013)

FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA

Arinina E., Rashid M., Antsiferov M.

(Rus)

№ 10 (2012)

Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa

Ametov A., Kulidzhanyan N., Shurupova I., Trifonova T., Antsiferov M.

(Rus)

№ 3 (2012)

TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS

Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.

№ 16 (2011)

DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

№ 16 (2010)

ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.

№ 16 (2010)

ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS

Demidova T., Demidova T.

№ 3 (2010)

New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation

Pavlova M., Pavlova M.

№ 20 (2009)

Primenenie bazal'no-bolyusnogo rezhima insulinoterapii u bol'nykh sakharnym diabetom tipa 2

Antsiferov M., Morgunov L.

№ 17 (2009)

INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2

Antsiferov M.

№ 3 (2009)

Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity

Antsiferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashintseva L., Budantseva T., Ivanova E., Anciferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashinceva L., Budanceva T., Ivanova E.

Том 29, № 4 (2022)

Problem of treatment adherence in patients with type 2 diabetes mellitus

Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.

(Rus)

Том 28, № 12 (2021)

Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?

Volkova N., Panenko S., Golubeva A.

(Rus)

Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy

Zelenina T., Salukhov V., Zemlyanoy A., Chebykina O.

(Rus)

The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience

Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.

(Rus)

Том 27, № 4 (2020)

Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors

Chernikova N., Knyshenko O.

(Rus)

Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts

Expert C.

(Rus)

№ 11 (2018)

Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism

Verbovoy A., Lomonova T., Sharonova L.

(Rus)

№ 4 (2018)

ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE

Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.

(Rus)

№ 6 (2017)

THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS

Shevkunova N.

(Rus)

№ 16 (2016)

Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus

Antsiferov M.

(Rus)

№ 17 (2015)

Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa

Galstyan G.

(Rus)

№ 5 (2015)

Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa

Ametov A.

(Rus)

№ 16 (2014)

Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya

Zaytseva N., Shamkhalova M.

(Rus)

№ 3 (2012)

SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Nikonova T., Nikonova T.

№ 3 (2011)

CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS

Antsiferov M., Antsiferov M.

№ 16 (2010)

POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR

Zanozina O., Zanozina O.

№ 16 (2010)

POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY

Antsiferov M., Zilov A., Antsiferov M., Zilov A.

№ 3 (2010)

Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"

Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.

№ 3 (2009)

Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus

Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.

Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy

Kurnikova I.

(Rus)

Том 28, № 12 (2021)

Insulin resistance - a common enemy for endocrinologists and cardiologists

Verbovoy A., Dolgikh Y.

(Rus)

The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus

Shevkunova N., Vorobyov M., Gushchin V.

(Rus)

Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»

Antsiferov M., Galstyan G.

(Rus)

Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice

Markova T.

(Rus)

The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)

Antsiferov M., Kvasnikov B.

(Rus)

№ 11 (2018)

Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow

Demidov N., Mishra O., Safronov T., Antsiferov M.

(Rus)

№ 4 (2018)

NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.

(Rus)

№ 16 (2017)

The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice

Antsiferov M.

(Rus)

№ 16 (2016)

Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients

Kovrigina E., Tyulganova V.

(Rus)

№ 5 (2016)

POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS

Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.

(Rus)

№ 2 (2016)

ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS

Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.

(Rus)

№ 5 (2015)

Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN

Chernikova N., Ivanova L., Abaeva F.

(Rus)

№ 16 (2014)

Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki

Surkova E.

(Rus)

№ 5 (2014)

METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Petunina N., Kuzina I.

(Rus)

№ 16 (2013)

Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa

Statsenko M., Derevyanchenko M.

(Rus)

№ 10 (2013)

Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa

Demidova I., Boeva V.

(Rus)

№ 5 (2013)

INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY

Antsiferov M., Schemthaner G., Ametov A.

(Rus)

№ 16 (2012)

Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Dorofeeva L.

(Rus)

№ 16 (2012)

Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike

Ametov A., Brashchenkova A.

(Rus)

№ 9 (2012)

METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA

Verbovoy A., Vorozhtsova E., Orlova T.

(Rus)

№ 3 (2012)

HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?

Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.

№ 16 (2011)

SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.

№ 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

№ 17 (2009)

ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2

Petunina N., Antsiferov M.

№ 3 (2009)

Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus

Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.